A229000 Share Price Performance
₩1,488.00
-827.00 (-35.72%)
Price ₩1,488.00
Share Price₩1,488.00
Gencurix Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A229000 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Gencurix Inc. Key Details
Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
- -778.53
- 62.26%
- -369.77%
- 105.4%
About A229000
- Founded
- 2011
- Employees
- 72
- CEO
- WebsiteView website
Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
